Trump Kills Key Drug Price Proposal He Once Embraced

Kaiser Health News

July 23rd, 2019 – Prescription drug costs are a major concern for consumers and a fiscal challenge for public and private payers. In response, lawmakers are considering a broad range of policy options, including allowing the federal government to negotiate the price of prescription drugs on behalf of people enrolled in Medicare Part D drug plans, which is prohibited under current law.

READ MORE

Be the first to comment

Leave a Reply

Your email address will not be published.


*